Send to

Choose Destination
PLoS One. 2017 Sep 7;12(9):e0183894. doi: 10.1371/journal.pone.0183894. eCollection 2017.

Range of glucose as a glycemic variability and 3-month outcome in diabetic patients with acute ischemic stroke.

Author information

Department of Neurology, Hanyang University School of Medicine, Seoul, Republic of Korea.
Department of Neurology, Chuncheon Sacred Heart Hospital, Chuncheon, Republic of Korea.
Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea.
Department of Neurology, Seoul National University Seoul Metropolitan Government Boramae Medical Center, Seoul, Republic of Korea.
Department of Neurology, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Department of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Department of Neurology, Chung-Ang University Hospital, Seoul, Republic of Korea.


Glycemic variability (GV) is reportedly a predictor for poor outcome in various clinical conditions. We aimed to assess whether GV during hospital admission is associated with poor outcomes in patients with acute ischemic stroke (AIS) and diabetes. We prospectively enrolled consecutive patients with AIS from the registry of 6 tertiary hospitals between January 2013 and December 2014. For the GV index, we used a glucose level range that was divided into 4 quartiles. Multivariable binary and ordinal logistic regression analyses were performed to determine the association between GV and the modified Rankin Scale score (3-6) at 3 months. We enrolled 1,504 patients with AIS and diabetes (mean age, 68.1 years; male, 57.2%), of which 35.1% had poor outcomes at 3 months. An increasing glucose range quartile was positively associated with initial neurologic severity and development of hypoglycemia during hospital admission. Multivariable analysis showed that the glucose level range quartile was associated with poor outcomes, even after adjusting for the number of glucose measurement and hypoglycemia (odds ratio [OR] Q2 vs. Q1: 1.50, 95% confidence interval [CI]: 1.02-2.18; OR Q3 vs. Q1: 2.01, 95% CI: 1.34-3.01; OR Q4 vs. Q1: 1.98, 95% CI: 1.22-3.23). These associations remained significant after dichotomization according to glycated hemoglobin levels at admission. An increasing glucose level range as a GV index during hospital admission was associated with poor functional outcomes at 3 months in patients with AIS and diabetes.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center